Financials
- Market Capitalization 12.5 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-34.99
Fiyat/satışlar oranı
11.04
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 706 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 239.01 USD | +0.40% | -2.34% | +3.53% | +70.72% | 15.00 B USD | ||
| 740 | EXEL Exelixis, Inc. - Common Stock | 55.83 USD | +0.11% | +0.76% | +4.67% | +43.01% | 14.03 B USD | ||
| 820 | SMMT Summit Therapeutics Inc. - Common Stock | 15.17 USD | -1.94% | -1.69% | +7.44% | -23.62% | 11.77 B USD | ||
| 824 | AXSM Axsome Therapeutics, Inc. - Common Stock | 233.84 USD | -0.60% | -5.19% | -8.31% | +79.60% | 12.03 B USD |